You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

List of Excipients in API lenacapavir sodium

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing lenacapavir sodium

Subscribe to access the full database, or Subscribe
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Gilead Sciences	SUNLENCA	lenacapavir sodium	61958-3001	CELLULOSE, MICROCRYSTALLINE	2027-12-22
Gilead Sciences	SUNLENCA	lenacapavir sodium	61958-3001	COPOVIDONE K25-31	2027-12-22
Gilead Sciences	SUNLENCA	lenacapavir sodium	61958-3001	CROSCARMELLOSE SODIUM	2027-12-22
Gilead Sciences	SUNLENCA	lenacapavir sodium	61958-3001	MAGNESIUM STEARATE	2027-12-22
Gilead Sciences	SUNLENCA	lenacapavir sodium	61958-3001	MANNITOL	2027-12-22
Gilead Sciences	SUNLENCA	lenacapavir sodium	61958-3001	METHYL ALCOHOL	2027-12-22
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for lenacapavir sodium

Excipient focus: CELLULOSE, MICROCRYSTALLINE

lenacapavir sodium drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Gilead Sciences	lenacapavir sodium	61958-3001
>Company	>Ingredient	>NDC

lenacapavir sodium drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: COPOVIDONE K25-31

lenacapavir sodium drug variants containing COPOVIDONE K25-31

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Gilead Sciences	lenacapavir sodium	61958-3001
>Company	>Ingredient	>NDC

lenacapavir sodium drug variants not containing COPOVIDONE K25-31

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSCARMELLOSE SODIUM

lenacapavir sodium drug variants containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Gilead Sciences	lenacapavir sodium	61958-3001
>Company	>Ingredient	>NDC

lenacapavir sodium drug variants not containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

lenacapavir sodium drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Gilead Sciences	lenacapavir sodium	61958-3001
>Company	>Ingredient	>NDC

lenacapavir sodium drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MANNITOL

lenacapavir sodium drug variants containing MANNITOL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Gilead Sciences	lenacapavir sodium	61958-3001
>Company	>Ingredient	>NDC

lenacapavir sodium drug variants not containing MANNITOL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: METHYL ALCOHOL

lenacapavir sodium drug variants containing METHYL ALCOHOL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Gilead Sciences	lenacapavir sodium	61958-3001
>Company	>Ingredient	>NDC

lenacapavir sodium drug variants not containing METHYL ALCOHOL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLOXAMER 407

lenacapavir sodium drug variants containing POLOXAMER 407

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Gilead Sciences	lenacapavir sodium	61958-3001
>Company	>Ingredient	>NDC

lenacapavir sodium drug variants not containing POLOXAMER 407

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.